What if stem cell treatments could help those with COVID-19?
What if pneumonia brought on by the virus could be cured?
That’s what we here at Blue Horizon are trying to find out. Our previous studies have shown that mesenchymal stem cells from the human umbilical cord have immunomodulatory, antimicrobial, anti-inflammatory and tissue repair functions, being a great potential for the prevention and treatment of viral diseases.
Presently we are in the process of submission and obtaining an endorsement from the Food and Drug Administration (FDA) to initiate the clinical trial of the human umbilical cord-derived stem cell administration in patients with severe COVID-19 pneumonia.
Application of the high-quality clinical-grade stem cell source is critical for the successful development and conduct of our study. We are seeking funding to incorporate high-quality stem cells in our study and initiate FDA endorsed clinical trials.